Vitrectomy Devices Market to reach USD 1.89 billion by 2032 and grow at a CAGR of 5.28%

The global vitrectomy devices market is experiencing robust growth due to the rising incidence of retinal-related diabetic cases that lead to most vision impairments. This is one of the primary causes of blindness in the working-age population in the world. This trend has increased the requirement for vitrectomy procedures, especially in cases involving vitreous hemorrhage and tractional retinal detachment. The diabetic retinopathy condition affected about 7.7 million Americans in 2018, according to projections from the National Eye Institute, this figure will increase to 11.3 million by 2030, making patients a powerful force for advanced vitrectomy devices. Globally, approximately 422 million individuals are affected by diabetes, with the majority living in low- and middle-income countries. Each year, diabetes-related vision complications necessitate over 1 million vitrectomy surgeries, contributing significantly to the demand for vitrectomy devices. Additionally, diabetes directly results in around 1.5 million deaths annually, highlighting the crucial role of these devices in managing diabetes-induced eye conditions and reducing the risk of vision loss.